Organ transplantation is a critical medical procedure that can save lives, yet in many parts of the world, including Central Asia, the practice faces significant challenges and cultural barriers. Let’s dive deeper into why organ donation after death struggles to take root across countries like Kazakhstan. In Kazakhstan, as in many Central Asian nations, organ
Regeneron, a leading pharmaceutical company, recently unveiled compelling data regarding the efficacy of its immunotherapy drug, Libtayo, in treating high-risk cutaneous squamous cell carcinoma (CSCC) as an adjuvant therapy. This development comes at a time when competing PD-1 inhibitor Keytruda faces challenges in the same area. According to Regeneron’s findings presented at the 2025 American
In a groundbreaking development, China’s National Medical Products Administration (NMPA) has conditionally approved Zymeworks’ zanidatamab for individuals battling unresectable or metastatic human epidermal growth factor receptor 2-positive (HER2+) biliary tract cancer (BTC). This approval is a significant milestone as zanidatamab becomes the first dual HER2-targeted bispecific antibody sanctioned for this particular use in China, particularly
Organ transplantation is a critical medical procedure that can save lives, yet in many parts of the world, including Central Asia, the practice faces significant challenges and cultural barriers. Let’s dive deeper into why organ donation after death struggles to take root across countries like Kazakhstan. In Kazakhstan, as in many Central Asian nations, organ
Regeneron, a leading pharmaceutical company, recently unveiled compelling data regarding the efficacy of its immunotherapy drug, Libtayo, in treating high-risk cutaneous squamous cell carcinoma (CSCC) as an adjuvant therapy. This development comes at a time when competing PD-1 inhibitor Keytruda faces challenges in the same area. According to Regeneron’s findings presented at the 2025 American
In a groundbreaking development, China’s National Medical Products Administration (NMPA) has conditionally approved Zymeworks’ zanidatamab for individuals battling unresectable or metastatic human epidermal growth factor receptor 2-positive (HER2+) biliary tract cancer (BTC). This approval is a significant milestone as zanidatamab becomes the first dual HER2-targeted bispecific antibody sanctioned for this particular use in China, particularly
In today’s digital age, where screens are omnipresent, a concerning link has emerged between teenagers’ screen time and their health. Specifically, recent studies have highlighted the impact of excessive screen time on teen girls, revealing a connection to poor sleep quality and increased feelings of depression. The allure of smartphones, tablets, computers, and other digital
The World Health Assembly, a significant annual gathering hosted by the WHO, is set to address crucial global health issues this year. From discussing a potential pandemic treaty to grappling with budget cuts impacting healthcare systems worldwide, the agenda is packed with pressing matters that demand attention. As delegates from various countries convene for this
Joe Biden, the former president of the United States, recently disclosed his diagnosis of prostate cancer. This news has sparked discussions about this particular type of cancer that affects many men worldwide. Prostate cancer is a significant health concern among men, with statistics indicating its prevalence in older age groups. It is crucial for men
In a world where cooperation and unity are essential, countries recently came together to address one of the most pressing issues facing humanity – pandemics. The annual World Health Organization (WHO) meeting held in Geneva was the stage for a landmark event where nations signed off on a global pandemic treaty. The atmosphere in Geneva